CSIR launches compendium of Indian tech for COVID-19

The Council of Scientific & Industrial Research (CSIR) on May 6 published the “Compendium of Indian Technologies for Combating COVID-19 (Tracing, Testing and Treating)” that will provide easy access to innovations related to battling the Coronavirus disease (COVID-19)

May 6, 2020

Most of these technologies in the compendium are proof-of-concept (POC) tested that can help entrepreneurs to take the product to market faster

The compendium will benefit industries, MSMEs, startups and the public at large as the Indian economy comes out of the nationwide lockdown

Indian researchers have been working on new drugs, vaccines, genome sequencing, plasma therapy, PPEs and medical devices for the pandemic

The COVID-19 has claimed over 240,000 lives between December 2019 and April 2020 while nearly 3.5 million people have contracted the disease

The Council of Scientific & Industrial Research (CSIR) on May 6 published the “Compendium of Indian Technologies for Combating COVID-19 (Tracing, Testing and Treating)” that will provide easy access to innovations related to battling the Coronavirus disease (COVID-19). The compendium carries information about 200 COVID-19-related Indian technologies, ongoing research activities, technologies available for commercialisation, initiatives, and efforts taken by the Government of India. Most of these technologies are proof-of-concept (POC) tested that can help entrepreneurs to take the product to market faster. 

The National Research Development Corporation (NRDC), which compiled the compendium, said that it includes the most relevant and emerging indigenously developed technological innovations, including those which are at the research stage. The move will greatly benefit industries, MSMEs, startups, and the public at large as the Indian economy comes out of the lockdown enforced to curb the spread of the Coronavirus disease. It will also serve as a ready-reference for policymakers, research scholars, scientists, and others. Several of the technologies are approved by the Indian Council of Medical Research (ICMR).

The COVID-19 has claimed over 240,000 lives between December 2019 and April 2020 while nearly 3.5 million people have contracted the disease in over 180 countries. During that period India reported around 42,500 Coronavirus cases and 1,300 deaths. The pandemic is expected to cost the global economy as much as US$2 trillion in 2020.

Indian researchers have been working on new drugs, vaccines, genome sequencing, plasma therapy, PPEs, and medical devices for COVID-19. The information in the compendium is sourced from various Government bodies and premier academic institutions, including Department of Science and Technology (DST), Ministry of Electronics and Information Technology (MeitY), Defence Research and Development Organisation (DRDO), Indian Institute(s) of Technology (IITs), Science and Engineering Research Board (SERB), National Innovation Foundation (NIF), Indian Institute of Science (IISc), among others.